Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Bionano Genomics, Inc. (BNGO) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Bionano Genomics, Inc. (BNGO) on October 30, 2026 is 1.14 $, −5.00 % on the day. Over 52 weeks the stock traded between 1.00 $ and 2.23 $; the price now sits 11 % of the way up that range. Over the past year the price changed by −37.19 %. Market capitalization is 6.20 million $, rank 23 among 23 stocks of the same industry with a known capitalization.
Bionano Genomics, Inc. trades on Nasdaq under the ticker BNGO. The company belongs to the Health care sector. The trading history on this page starts on 21 August 2018.
Over the past 52 weeks BNGO has traded between 1.00 $ and 2.23 $. As of 30 October 2026 the price stood 20.33 % of the way from the 52-week low to the high.
Over one year BNGO shares fell 37.19 %; over six months they fell 3.10 %. Volatility over 90 days is 59.40 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.2, below the sector median of 3.6. Price to book is 0.2, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Bionano Genomics, Inc. reported revenue of 30M $ and a net loss of 32M $ over the last four quarters. Net margin is −106.58 %. Revenue changed by +10.03 % year over year. Earnings per share are −3.01 $. Market capitalisation is 6M $.
BNGO has a return on equity of −101.76 %, below the sector median of −40.58 %. Return on assets is −67.58 %, below the sector median of −30.08 %. Operating margin is −106.68 %, below the sector median of −20.96 %.